Nara Health Raises $14M to Reinvent Health Insurance Through AI Benefits Administration and Alternative Health Plans
Nara Health, a Chicago-based startup, has closed $14 million in combined pre-seed and seed funding led by Khosla Ventures. The company is developing an AI-native Third Party Administration platform designed to overhaul employer-sponsored health benefits, with a particular focus on offering alternative health plans that reduce premium costs for the roughly 170 million Americans covered through their employers.
Key facts
- Nara Health raised $14 million across pre-seed and seed rounds
- Round was led by Khosla Ventures
- Company is headquartered in Chicago, IL
- Building an AI-native Third Party Administration (TPA) platform
- Target market: employer-sponsored health insurance covering ~170 million Americans
- Value proposition centers on alternative health plan models and reduced family premium costs
- Company is at an early (pre-seed/seed) stage with no disclosed customer base
Nara Health, a Chicago-based benefits technology startup, has secured $14 million in pre-seed and seed funding in a round led by Khosla Ventures, according to an announcement distributed via Business Wire. The capital will support the development of an AI-native Third Party Administration (TPA) platform that the company says is designed to fundamentally redesign how employers structure and administer health coverage.
The company is targeting one of the largest and most structurally entrenched segments of the U.S. healthcare system: employer-sponsored insurance, which covers an estimated 170 million Americans. Rising family premium costs have made this market an increasingly attractive target for technology-driven disruption, and Nara Health says its alternative health plan model is built to address affordability at the plan design level — not merely at the administrative layer.
The TPA model sits at the intersection of benefits administration, plan management, and claims processing — functions that have historically been dominated by large legacy carriers and incumbent administrators. By applying AI natively across these workflows, Nara Health is reportedly aiming to offer employers greater flexibility and cost control than traditional fully-insured or even standard self-insured arrangements.
Khosla Ventures, a Silicon Valley firm known for backing ambitious, technology-forward companies across healthcare and enterprise software, led the round. The firm's participation lends early institutional credibility to Nara Health's thesis.
As a pre-seed and seed stage company, Nara Health has not publicly disclosed named enterprise customers, specific product features, or detailed go-to-market timelines. The company's long-term trajectory will hinge on its ability to navigate complex regulatory requirements governing TPA operations, build trust with employers and brokers, and demonstrate measurable cost outcomes relative to incumbent solutions.
For HR and benefits leaders, Nara Health represents an early signal of a broader market movement: AI-native platforms aiming to compete not just at the surface of benefits administration tools, but at the core plan architecture level.
Employer-sponsored health benefits represent one of the largest cost centers for U.S. companies, yet the administration infrastructure underpinning it has seen relatively little AI-native disruption. Nara Health's entry — backed by Khosla Ventures — signals growing investor conviction that the TPA layer is ripe for reinvention. HR and benefits leaders should track this space: if AI-native TPAs can deliver on cost reduction and plan flexibility, they could reshape how mid-market and enterprise employers procure and administer health coverage.


